Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesGuidelines of care for the management of psoriasis and psoriatic arthritis
Journal of the American Academy of Dermatology, 08/26/09
Menter A et al. – The authors will discuss in detail the efficacy and safety, and offer recommendations for the use of the 3 most commonly used, and approved, traditional systemic agents: methotrexate, cyclosporine, and acitretin. The authors will also briefly discuss the available data for the use of azathioprine, fumaric acid esters, hydroxyurea, leflunomide, mycophenolate mofetil, sulfasalazine, tacrolimus, and 6–thioguanine in psoriasis.
Related Articles
The association between arthritis and psychiatric disorders; results from a longitudinal population-based study
Journal of Psychosomatic Research, 10/12/09
Relevance Score: 96%
Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort
Arthritis Research & Therapy, 10/02/09
Relevance Score: 95%
Pain in arthritis
European Journal of Pain, 11/17/09
Relevance Score: 94%
Psoriatic arthritis common in people with psoriasis
Internet Source, 11/06/09
Relevance Score: 93%
Rheumatoid Arthritis and Tuberculous Arthritis: Differentiating MRI Features
American Journal of Roentgenology, 10/26/09
Relevance Score: 93%
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Comorbidities in Patients with Psoriasis
American Journal of Medicine, 12/09/09
Site of psoriasis (scalp or intergluteal/perianal), >=3 affected sites, and nail dystrophy predicted psoriatic arthritis in incident psoriasis
Evidence-Based Medicine, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor